Avita Medical
(NASDAQ) RCEL
Avita Medical Financials at a Glance
Market Cap
$97.38M
Revenue (TTM)
$72.35M
Net Income (TTM)
-$45.34M
EPS (TTM)
-$1.57
P/E Ratio
-2.50
Dividend
$0.00
Beta (Volatility)
1.42 (Average)
Dividend
$0.00
Beta (Volatility)
1.42 (Average)
Price
$3.91
Volume
16.097
Open
$3.99
Price
$3.91
Volume
16.097
Open
$3.99
Previous Close
$3.92
Daily Range
$3.77 - $4.06
52-Week Range
$3.22 - $7.12
Estimated Earnings Date
May 7, 2026
Dividend
$0.00
Beta (Volatility)
1.42 (Average)
Price
$3.91
Volume
16.097
Open
$3.99
Previous Close
$3.92
Daily Range
$3.77 - $4.06
52-Week Range
$3.22 - $7.12
Estimated Earnings Date
May 7, 2026
RCEL News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Avita Medical
Industry
Biotechnology
Sector
Health CareEmployees
226
CEO
Cary Guy Vance, MBA
Website
www.avitamedical.comHeadquarters
Valencia, CA 91355, US
RCEL Financials
Key Financial Metrics (TTM)
Gross Margin
81.36%
Operating Margin
-54.61%
Net Income Margin
-62.67%
Return on Equity
305.45%
Return on Capital
-142.64%
Return on Assets
-87.96%
Earnings Yield
-40.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$97.38M
Shares Outstanding
24.84M
Volume
16.097
Avg. Volume
243.50K
Financials (TTM)
Gross Profit
$58.86M
Operating Income
-$39.51M
EBITDA
-$37.72M
Operating Cash Flow
-$30.96M
Capital Expenditure
$212.00K
Free Cash Flow
-$30.75M
Cash & ST Invst.
$14.26M
Total Debt
$1.98M
Avita Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$19.25M
+4.0%
Gross Profit
$15.73M
+0.3%
Gross Margin
81.70%
N/A
Market Cap
$97.38M
N/A
Market Cap/Employee
$419.40K
N/A
Employees
232.2
N/A
Net Income
-$10.61M
+23.4%
EBITDA
-$8.57M
+29.1%
Quarterly Fundamentals
Total Cash
$14.26M
-44.8%
Total Debt
$1.98M
-95.5%
Accounts Receivable
$9.89M
-18.6%
Inventory
$6.12M
-27.1%
Long Term Debt
$3.96M
-91.0%
Short Term Debt
$46.14M
N/A
Return on Assets
-87.96%
N/A
Return on Invested Capital
2.61%
N/A
Free Cash Flow
-$10.09M
+4.3%
Operating Cash Flow
-$10.07M
+2.3%